Jeffrey T. Holt

2.6k total citations
40 papers, 2.0k citations indexed

About

Jeffrey T. Holt is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Jeffrey T. Holt has authored 40 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 21 papers in Genetics and 6 papers in Oncology. Recurrent topics in Jeffrey T. Holt's work include BRCA gene mutations in cancer (12 papers), CRISPR and Genetic Engineering (12 papers) and Virus-based gene therapy research (9 papers). Jeffrey T. Holt is often cited by papers focused on BRCA gene mutations in cancer (12 papers), CRISPR and Genetic Engineering (12 papers) and Virus-based gene therapy research (9 papers). Jeffrey T. Holt collaborates with scholars based in United States, Canada and Ukraine. Jeffrey T. Holt's co-authors include Marilyn E. Thompson, David L. Page, Patrice S. Obermiller, Derek W. Abbott, Roy A. Jensen, Cheryl Robinson‐Benion, Lynn M. Matrisian, Lawrence D. Kerr, Carlos L. Arteaga and Mary‐Claire King and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Jeffrey T. Holt

39 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey T. Holt United States 17 1.5k 997 476 377 176 40 2.0k
Irmgard Irminger‐Finger Switzerland 27 1.3k 0.8× 456 0.5× 451 0.9× 348 0.9× 122 0.7× 54 1.9k
Yusuke Nakamura Japan 24 1.2k 0.8× 260 0.3× 457 1.0× 308 0.8× 200 1.1× 38 1.8k
Jiaxue Wu China 28 2.0k 1.3× 387 0.4× 675 1.4× 350 0.9× 105 0.6× 53 2.6k
Shang Li Singapore 21 2.1k 1.4× 655 0.7× 542 1.1× 415 1.1× 86 0.5× 52 2.8k
Gary K. Yiu United States 13 990 0.7× 252 0.3× 379 0.8× 245 0.6× 87 0.5× 15 1.5k
Bastiaan Evers Netherlands 21 1.8k 1.2× 241 0.2× 995 2.1× 369 1.0× 145 0.8× 39 2.4k
Jean Gudas United States 25 1.3k 0.8× 399 0.4× 945 2.0× 404 1.1× 65 0.4× 44 2.1k
Michael Mitchell United Kingdom 9 1.7k 1.1× 227 0.2× 402 0.8× 468 1.2× 262 1.5× 12 2.1k
Jaideep Chaudhary United States 24 1.1k 0.7× 334 0.3× 228 0.5× 264 0.7× 56 0.3× 81 1.7k
M. J. Birrer United States 14 947 0.6× 191 0.2× 537 1.1× 337 0.9× 143 0.8× 24 1.5k

Countries citing papers authored by Jeffrey T. Holt

Since Specialization
Citations

This map shows the geographic impact of Jeffrey T. Holt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey T. Holt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey T. Holt more than expected).

Fields of papers citing papers by Jeffrey T. Holt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey T. Holt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey T. Holt. The network helps show where Jeffrey T. Holt may publish in the future.

Co-authorship network of co-authors of Jeffrey T. Holt

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey T. Holt. A scholar is included among the top collaborators of Jeffrey T. Holt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey T. Holt. Jeffrey T. Holt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nelson, Andrew C. & Jeffrey T. Holt. (2010). Impact of RING and BRCT Domain Mutations on BRCA1 Protein Stability, Localization and Recruitment to DNA Damage. Radiation Research. 174(1). 1–13. 31 indexed citations
2.
Holt, Jeffrey T., et al.. (2008). Restoration of CAPAN-1 cells with functional BRCA2 provides insight into the DNA repair activity of individuals who are heterozygous for BRCA2 mutations. Cancer Genetics and Cytogenetics. 186(2). 85–94. 9 indexed citations
3.
Yee, Cindy J., Randall L. Woltjer, Rebecca L. Townsend, et al.. (2007). Effects of BRCA1 Transgene Expression on Murine Mammary Gland Development and Mutagen-Induced Mammary Neoplasia. International Journal of Biological Sciences. 3(5). 281–291. 11 indexed citations
4.
Thompson, Marilyn E., Cheryl Robinson‐Benion, & Jeffrey T. Holt. (2005). An Amino-terminal Motif Functions as a Second Nuclear Export Sequence in BRCA1. Journal of Biological Chemistry. 280(23). 21854–21857. 38 indexed citations
5.
Sekhar, Konjeti R., Douglas R. Spitz, Trung Thanh Nguyen, et al.. (2002). Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of γ-glutamylcysteine synthetase. Free Radical Biology and Medicine. 32(7). 650–662. 71 indexed citations
6.
Abbott, Derek W., Marilyn E. Thompson, Cheryl Robinson‐Benion, et al.. (1999). BRCA1 Expression Restores Radiation Resistance in BRCA1-defective Cancer Cells through Enhancement of Transcription-coupled DNA Repair. Journal of Biological Chemistry. 274(26). 18808–18812. 183 indexed citations
7.
Abbott, Derek W. & Jeffrey T. Holt. (1999). Mitogen-activated Protein Kinase Kinase 2 Activation Is Essential for Progression through the G2/M Checkpoint Arrest in Cells Exposed to Ionizing Radiation. Journal of Biological Chemistry. 274(5). 2732–2742. 115 indexed citations
8.
Obermiller, Patrice S., David L. Tait, & Jeffrey T. Holt. (1999). Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies. Breast Cancer Research. 2(1). 28–31. 15 indexed citations
9.
Steiner, Mitchell S., Catherine T. Anthony, Yi Lü, & Jeffrey T. Holt. (1998). Antisense c- myc Retroviral Vector Suppresses Established Human Prostate Cancer. Human Gene Therapy. 9(5). 747–755. 63 indexed citations
10.
Tait, David L., Roy A. Jensen, Jeffrey T. Holt, et al.. (1998). Gene Therapy for Breast and Ovarian Cancer with BRCA1. Breast Disease. 10(1-2). 89–98. 4 indexed citations
11.
Jensen, Roy A., Marilyn E. Thompson, Thomas L. Jetton, et al.. (1996). Reply to “…and secreted tumour suppressors”. Nature Genetics. 13(3). 269–272. 17 indexed citations
12.
Jensen, Roy A., Marilyn E. Thompson, Thomas L. Jetton, et al.. (1996). BRCA1 is secreted and exhibits properties of a granin. Nature Genetics. 12(3). 303–308. 145 indexed citations
13.
Holt, Jeffrey T., Marilyn E. Thompson, Csilla I. Szabo, et al.. (1996). Growth Retardation and Tumour Inhibition by BRCA1. Obstetrical & Gynecological Survey. 51(7). 411–413. 1 indexed citations
14.
Holt, Jeffrey T.. (1996). Antisense therapeutics. Molecular Medicine Today. 2(5). 184–185. 10 indexed citations
15.
Holt, Jeffrey T., Marilyn E. Thompson, Csilla I. Szabo, et al.. (1996). Growth retardation and tumour inhibition by BRCA1. Nature Genetics. 12(3). 298–302. 290 indexed citations
16.
Thompson, Marilyn E., et al.. (1995). Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genetics. 9(4). 444–450. 474 indexed citations
17.
Holt, Jeffrey T.. (1993). Fos and Jun: Inducible transcription factors regulating growth of normal and transformed cells. Cancer treatment and research. 63. 301–311. 11 indexed citations
18.
Holt, Jeffrey T.. (1993). Antisense Rescue Defines Specialized and Generalized Functional Domains for c-Fos Protein. Molecular and Cellular Biology. 13(6). 3821–3830. 2 indexed citations
19.
Kamata, Nobuyuki & Jeffrey T. Holt. (1992). Inhibitory Effect of Myristylation on Transrepression by FBR (Gag-Fos) Protein. Molecular and Cellular Biology. 12(2). 876–882. 16 indexed citations
20.
Holt, Jeffrey T., Robert L. Redner, & Arthur W. Nienhuis. (1988). An oligomer Complementary to c- myc mRNA Inhibits Proliferation of HL-60 Promyelocytic Cells and Induces Differentiation. Molecular and Cellular Biology. 8(2). 963–973. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irmgard Irminger‐Finger Breakdown of academic impact, for papers by Yusuke Nakamura Breakdown of academic impact, for papers by Jiaxue Wu Breakdown of academic impact, for papers by Shang Li Breakdown of academic impact, for papers by Gary K. Yiu Breakdown of academic impact, for papers by Bastiaan Evers Breakdown of academic impact, for papers by Jean Gudas Breakdown of academic impact, for papers by Michael Mitchell Breakdown of academic impact, for papers by Jaideep Chaudhary Breakdown of academic impact, for papers by M. J. Birrer
Rankless by CCL
2026